Use of metallic gold as a non-toxic immune suppressor
Bio-release of gold ions from gold implants
Berlock ApS is a Research & Development Company with activities in the field of biomedical technology. The company has close connections to universities and research institutes.
Our specific field of interest is the application of millimetre and > 20 micron seized gold implants as local providers of gold ions in a biomedical context. Focus is on the treatment of inflammation, the third fastest growing therapeutic area. Berlock own several patents dealing with the use of gold implants as a provider of curative gold ions.
A substantial scientific literature, on the treatment of rheumatic diseases with gold ion containing drugs like Myocrisin® has indisputably shown that gold ions suppress inflammation. There exist thus clear proofs for gold ions being curative.
When gold implants are used as providers of gold ions the treatment is local, i.e. no spread to the rest of the body. Gold ions are only found in a mm narrow 3D zone around the implant.
In noninflamed tissue a gold implant will continue to release tiny amounts of gold ions (i.e. dicyanoaurate ions). This state could be called the resting stage, but if the locality are or become inflamed the amount of bio-released gold ions will grow because of the local raise in number of macrophages. ‘Gold implant therapy’ – Auromedication - is a safe way of treating locale/regional autoimmune maladies, and it is without known side effects.
The Berlock patents and patent applications aim at protecting the use of gold,
as a pharmaceutical prescription of gold ions.
The Berlock gold concept is treatment of inflammation with metallic gold simplants/particles and its hallmarks are:
Metallic gold is non-toxic
Metallic gold can be used in various forms:
Injection of gold particles BerlockMicroImplants (BMI) into or around joints, into cerebrospinal fluid, along sutured wounds in skin as well as in uterus and other internal organs, into gingiva in patients with paradentosis or inflamed bursae etc.
Injection of 'macro' implants i.e. mm sized implants called BerlocckImplants (BI)
Injection of 'micro' implants i.e. micron sized implants called BerlockMicroImplants (BMI) around or into inflammatory joints, or other tissues suffering autoimmune inflammation
Incomplete/patchy gilding of prostheses to secure a life long intimate conextion between bone and prosthesis l
Gold particles on the surface of breast prothesis, hernia meshes etc. to secure a thin elastic capsules around the implant.
Injection of gold particles BMI into dermis of skin suffering from inflammation (eczema/ psoriasis)
Treatment of mamma prosthesis, stents, meshes for hernia, umbilicus, wounds etc, with micron sized gold particle BMI, to ensure that the connective capsules around the foreign bodies stay thin and elastic.
Peroral treatment with tablets containing gold particles BMI to suppress inflammation caused by wounds in stomach and guts.
The potential targets are many
The technology is safe, efficient and unique
In broad terms, the BMI and BI aim at establishing a local, non-toxic gold cure in a sphere around the application site.
Berlock has decided on a focused strategy, which is to initiate, in parallel, proofs of concept on four application areas:
· Bone- prosthesis securing
· Joint inflammation (arthritis, arthrosis)
· Inner and outer epithelial surfaces lesions
· Sterile inflammation in the central nervous system
· Fibrous capsules around operation-mesh and prosthesis e.g. mamma prosthesis